Thermo Fisher Scientific Inc. (NYSE:TMO) is recommended as one of the best medical stocks to buy now, with analysts setting price targets between $560.00 and $570.00. The company offers a range of services and products in the areas of analysis, research, diagnostics, and discovery across various segments.

Barclays recently upgraded Thermo Fisher Scientific Inc. (NYSE:TMO) to Overweight from Equal Weight, increasing the price target to $550 from $490. The company continues to provide analytical instruments, reagents, equipment, software, and other services for various scientific and medical purposes.

While Thermo Fisher Scientific Inc. (NYSE:TMO) presents investment potential, some AI stocks may offer greater upside potential with less downside risk. Investors looking for undervalued AI stocks that could benefit from current trends can explore other options. Consider reviewing the free report on the best short-term AI stock for more insights and opportunities.

Read more at Yahoo Finance: Where is Thermo Fisher Scientific (TMO) Headed According to Analysts?